Two New Italian €500m Funds for Innovative Drugs for Cancer, Hep C
Executive Summary
New medicines for hepatitis C and cancer are among innovative therapies benefiting from two special funds set up by the Italian government.
You may also be interested in...
New Italian Rules Ease The Way To Personal Import Of Cheaper Medicines
A circular issued by the Italian health ministry has relaxed the rules on the personal import of medicines that are approved elsewhere but not in Italy, and extended the mechanism to products that are approved in Italy but inaccessible to certain patients for eligibility or cost reasons.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.